Meta-analysis of bacterial resistance to macrolides

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 5, 2005, Pages 748-757

  Halpern, Michael T ^a   Schmier, Jordana K ^a   Snyder, Lia M ^a,d   Asche, Carl ^b,e   Sarocco, Phillip W ^b   Lavin, Bruce ^b   Nieman, Richard ^b   Mandell, Lionel A ^c  

^a EXPONENT INC   (United States)

^b SANOFI   (France)

^c MCMASTER UNIVERSITY   (Canada)

^d Advisory Board Company   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Antibiotic resistance; Respiratory tract infections; Streptococci

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ASIA; BACTERIUM ISOLATION; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; DATA ANALYSIS; EMBASE; GEOGRAPHY; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; RESPIRATORY TRACT INFECTION; REVIEW; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNITED STATES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 18844400907     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki060     Document Type: Review

References (42)

1. File, T. M., Jr & Tan, J. S. (2003). International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides. Drugs 63, 181-205.
2. Doern, G. V. (2001). Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clinical Infectious Diseases 33, Suppl. 3, S187-92.
3. Interagency Task Force on Antimicrobial Resistance. (2003). A Public Health Action Plan to Combat Antimicrobial Resistance. Part 1: Domestic Issues. [Online]. http://www.cdc.gov/drugresistance/actionplan/aractionplan.pdf (20 September 2004, date last accessed) (2003)
4. DerSimonian, R. & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-88.
5. Farrington, C. P. & Manning, G. (1990). Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Statistics in Medicine 9, 1447-54.
6. Naaber, P., Tamm, E., Putsepp, A. et al. (2000). Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clinical Microbiology and Infection 6, 675-7.
7. Farrell, D. J., Morrissey, I., Bakker, S. et al. (2002). Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. Journal of Antimicrobial Chemotherapy 50, Suppl. S1, 39-47.
8. Felmingham, D., Reinert, R. R., Hirakata, Y. et al. (2002). Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. Journal of Antimicrobial Chemotherapy 50, Suppl. S1, 25-37.
9. Bonvehi, P., Weber, K., Busman, T. et al. (2003). Comparison of clarithromycin and amoxicillin/clavulanic acid for community-acquired pneumonia in an era of drug-resistant Streptococcus pneumoniae. Clinical Drug Investigation 23, 491-501.
10. Nuermberger, E. & Bishai, W. R. (2004). The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Clinical Infectious Diseases 38, 99-103.
11. Cosgrove, S. E. & Carmeli, Y. (2003). The impact of antimicrobial resistance on health and economic outcomes. Clinical Infectious Diseases 36, 1433-7.
12. Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M. et al. (2002). Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Archives of Internal Medicine 162, 185-90.
13. Capitano, B., Leshem, O. A., Nightingale, C. H. et al. (2003). Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility. Journal of the American Geriatrics Society 51, 10-16.
14. Kim, T., Oh, P. I. & Simor, A. E. (2001). The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infection Control and Hospital Epidemiology 22, 99 -104.
15. Abdel-Haq, N., Abuhammour, W., Asmar, B. et al. (1999). Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis. Pediatric Infectious Disease Journal 18, 647-9.
16. Anzueto, A., Gotfried, M., Wikler, M. A. et al. (2002). Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis. Clinical Therapeutics 24, 906-17.
17. Avanzini, C., Bosio, K., Volpe, G. et al. (2000). Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD. Microbial Drug Resistance 6, 289-95.
18. Bassetti, M., Manno, G., Collida, A. et al. (2000). Erythromycin resistance in Streptococcus pyogenes in Italy. Emerging Infectious Diseases 6, 180-3.
19. Boost, M. V., O'Donoghue, M. M. & Dooley, J. S. (2001). Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong. Epidemiology and Infection 127, 49-55.
20. Chiu, S. S., Ho, P. L., Chow, F. K. et al. (2001). Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrobial Agents and Chemotherapy 45, 2765-70.
21. Ciftci, E., Dogru, U., Guriz, H. et al. (2002). Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish children. Pediatrics International 44, 647-51.
22. Dellamonica, P., Pradier, C., Leroy, J. et al. (2002). Epidemiology and antibiotic susceptibility of nasopharyngeal S. pneumoniae and H. influenzae isolated from children attending day-care centers in 3 french departments. Médecine et Maladies infectieuses 32, 650-61.
23. Ford-Jones, E. L., Friedberg, J., McGeer, A. et al. (2002). Microbiologic findings and risk factors for antimicrobial resistance at myringotomy for tympanostomy tube placement - a prospective study of 601 children in Toronto. International Journal of Pediatric Otorhinolaryngology 66, 227-42.
24. Ghaffar, F., Muniz, L. S., Katz, K. et al. (2000). Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Clinical Infectious Diseases 31, 875-80.
25. Gray, G. C., Witucki, P. J., Gould, M. T. et al. (2001). Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population. Clinical Infectious Diseases 33, 983-9.
26. Herruzo, R., Chamorro, L., Garcia, M. E. et al. (2002). Prevalence and antimicrobial-resistance of S. pneumoniae and S. pyogenes in healthy children in the region of Madrid. International Journal of Pediatric Otorhinolaryngology 65, 117-23.
27. Hjaltested, E. K. R., Bernatoniene, J., Erlendsdottir, H. et al. (2003). Resistance in respiratory tract pathogens and antimicrobial use in Icelandic and Lithuanian children. Scandinavian Journal of Infectious Diseases 35, 21-6.
28. Huebner, R. E., Wasas, A. D., Hockman, M. et al. (2003). Bacterial aetiology of non-resolving otitis media in South African children. Journal of Laryngology and Otology 117, 169-72.
29. Jones, R. N., Andes, D. R., Mandell, L. A. et al. (2002). Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 44, 93-100.
30. Kacou-N'Douba, A., Bouzid, S. A., Guessennd, K. N. et al. (2001). Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae in healthy carriers: report of a study in 5-year-olds in Marcory, Abidjan, Cote d'lvoire. Annals of Tropical Paediatrics: International Child Health 21, 149-54.
31. Li, W. C., Chiu, N. C., Hsu, C. H. et al. (2001). Pathogens in the middle ear effusion of children with persistent otitis media: implications of drug resistance and complications. Journal of Microbiology, Immunology, and Infection 34, 190-4.
32. Lopez, B., Cima, M. D., Vazquez, F. et al. (1999). Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children. European Journal of Clinical Microbiology and Infectious Diseases 18, 771-6.
33. Mainous, A. G., 3rd, Evans, M. E., Hueston, W. J. et al. (1998). Patterns of antibiotic-resistant Streptococcus pneumoniae in children in a day-care setting. Journal of Family Practice 46, 142-6.
34. Nwabuisi, C. & Ologe, F. E. (2002). Pathogenic agents of chronic suppurative otitis media in llorin, Nigeria. East African Medical Journal 79, 202-5.
35. Pfaller, M. A. & Jones, R. N. (2002). Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections. Diagnostic Microbiology and Infectious Disease 44, 77-84.
36. Raz, R., Soboh, S., Much, A. et al. (1999). Pneumococcal carriage in geriatric institute residents. Infectious Diseases in Clinical Practice 8, 291-3.
37. Ronchetti, M. P., Guglielmi, F., Latini, L. et al. (1999). Resistance patterns of Streptococcus pneumoniae from children in central Italy. European Journal of Clinical Microbiology and Infectious Diseases 18, 376-9.
38. Rosenblut, A., Santolaya, M. E., Gonzalez, P. et al. (2001). Bacterial and viral etiology of acute otitis media in Chilean children. Pediatric Infectious Disease Journal 20, 501-7.
39. Samore, M. H., Magill, M. K., Alder, S. C. et al. (2001). High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108, 856-65.
40. Skull, S., Shelby-James, T., Morris, P. et al. (1999). Streptococcus pneumoniae antibiotic resistance in Northern Territory children in day care. Journal of Paediatrics and Child Health 35, 466-71.
41. Sokol, W. (2001). Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. American Journal of Medicine 111, Suppl. 9A, 19S-24S.
42. Syrogiannopoulos, G. A., Grivea, I. N., Fitoussi, F. et al. (2001). High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatric Infectious Disease Journal 20, 863-8.